4 ms·
33 million new americans on the drug[1], $12 every three months, that's about $1.5 billion dollars a year of new business, by just issuing a new "guideline". In
by tremendo 13y ago
33 million new americans on the drug[1], $12 every three months, that's about $1.5 billion dollars a year of new business, by just issuing a new "guideline". In just one country. Not a profit source? I don't agree. Edited to add reference to the 33 million new users.
[1] http://www.washingtonpost.com/national/health-science/new-guidelines-could-have-far-more-americans-taking-statin-drugs-for-cholesterol/2013/11/12/7f249318-4be4-11e3-be6b-d3d28122e6d4_story.html http://www.washingtonpost.com/national/health-science/new-gu...
- carbocation 13y ago1) Statins save lives. 2) The people making the recommendations are not the people making money off of the drugs. 3) $1.5 billion is a minuscule slice of the US healthcare market. 4) At $0.13 per pill, it's kind of hard imagining a non-subsidized price getting much lower. What could be done to assuage your concerns?
- tremendo 13y ago1) We could go into a rabbit hole with this, I'm not going to, just will remark that there are plenty of credible (subjective I know) who believe statins at best replace one malady with another, they do lower cholesterol while not caring why it's high in the first place. They help people who have already have had a cardiac event, and up to 50 years old. Not older men, and in no case women. 2) No conflicts of interest? 3) I made no claim about slice size, it's still $1.5 Billion per year for one country, and that's not insignificant. 4) so, each pill is cheap.